Alignment Healthcare Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Buy" and an average price target of $24.08. The average 1-year stock price forecast is 79.57% higher than the current stock price, while the lowest is $16 (+19.31%) and the highest is $30 (+123.71%).

Price Target: $24.08 (+79.57%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$16	$24.08	$25	$30
Change	+19.31%	+79.57%	+86.43%	+123.71%

Analyst Ratings

The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	9	10	10	10	10	9
Buy	2	2	2	2	2	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	14	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Stansel J.P. Morgan	J.P. Morgan	Buy Maintains $26 → $22	Buy	Maintains	$26 → $22	+64.06%	Aug 4, 2026
Scott Fidel Goldman Sachs	Goldman Sachs	Buy Maintains $25	Buy	Maintains	$25	+86.43%	Aug 3, 2026
Parker Snure Raymond James	Raymond James	Buy Maintains $22 → $19	Buy	Maintains	$22 → $19	+41.69%	Aug 3, 2026
Gary Taylor TD Cowen	TD Cowen	Buy Reiterates $25 → $21	Buy	Reiterates	$25 → $21	+56.60%	Aug 3, 2026
Michael Craig Jones Bank of America Securities	Bank of America Securities	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jul 31, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.21B

from 3.95B

32.06%

from 3.95B

Revenue Next Year

6.50B

from 5.21B

24.64%

from 5.21B

EPS This Year

0.50

from 0.32

54.00%

from 0.32

EPS Next Year

0.75

from 0.50

52.02%

from 0.50

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.17B	1.43B	1.82B	2.70B	3.95B	5.21B
Revenue Growth	21.74%	22.81%	27.16%	48.25%	46.06%	32.06%
Net Income	-195.29M	-149.55M	-148.02M	-128.04M	-724.00K	39.29M
EPS	-	-	-	-	0.32	0.50
EPS Growth	-	-	-	-	-	54.00%
Forward PE	-	-	-	-	56.43	27.09
Free Cash Flow	-19.39M	-1.07M	-149.48M	122.27M	124.50M	154.60M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	5.2B
Avg	5.2B
Low	5.2B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	32.3%
Avg	32.1%
Low	31.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.50
Avg	0.50
Low	0.49

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	55.6%
Avg	54.0%
Low	52.4%